Limited Partnership Aequanimitas serves as Executive at Rani Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, Limited Partnership Aequanimitas has executed 2 insider transactions totaling $10.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 24, 2023 involved selling 5,265,165 shares valued at $10.6M.
Limited Partnership Aequanimitas currently holds 8,400 shares of Rani Therapeutics Holdings, Inc. (RANI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Limited Partnership Aequanimitas has been a net seller of RANI stock. They have purchased $50.7K and sold $10.6M worth of shares.
Limited Partnership Aequanimitas's most recent insider trade was on Nov 24, 2023, when they sold 5,265,165 shares at $2.01 per share.
Get notified when new Form 4 filings are submitted
| $6.03 |
| Discretionary |